{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:01:53Z","timestamp":1785438113477,"version":"3.56.0"},"reference-count":40,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Young Scientists Fund (Category C) of the National Natural Science Foundation of China","award":["82502037"],"award-info":[{"award-number":["82502037"]}]},{"name":"Young Scientists Fund (Category C) of the National Natural Science Foundation of China","award":["82503785"],"award-info":[{"award-number":["82503785"]}]},{"award":["82502037"],"award-info":[{"award-number":["82502037"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82503785"],"award-info":[{"award-number":["82503785"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["25cz020301-4806074"],"award-info":[{"award-number":["25cz020301-4806074"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["25cz020301-4805747"],"award-info":[{"award-number":["25cz020301-4805747"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["22cz020401-4811009"],"award-info":[{"award-number":["22cz020401-4811009"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2702500"],"award-info":[{"award-number":["2022YFC2702500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700700"],"award-info":[{"award-number":["2021YFC2700700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine","award":["FIRMA181104"],"award-info":[{"award-number":["FIRMA181104"]}]},{"award":["FIRMA181104"],"award-info":[{"award-number":["FIRMA181104"]}],"id":[{"id":"https:\/\/ror.org\/03jgxy838","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Placenta Accreta Spectrum (PAS) is a severe obstetric disorder characterized by excessive trophoblast invasion into the uterine myometrium, leading to life-threatening hemorrhage at delivery. While closely monitored, the molecular drivers of its progression remain poorly defined, hindering predictive and therapeutic strategies. Here, we employed longitudinal quantitative proteomics on maternal plasma from five PAS patients across gestation. We identified Keratin 6A (KRT6A) as a key biomarker whose plasma levels increase with PAS progression. Immunohistochemistry confirmed the specific upregulation of KRT6A in trophoblasts at the maternal\u2013fetal interface in PAS. Functional studies demonstrated that KRT6A overexpression significantly enhances the migration and invasion capabilities of trophoblast cell lines in vitro, without affecting proliferation or apoptosis. Integrative bioinformatics analysis linked KRT6A to the activation of the MYC signaling pathway, a known driver of invasiveness. Our data establish KRT6A as a plasma biomarker correlating with PAS severity and a functional regulator of trophoblast invasiveness. These findings suggest a novel mechanism wherein KRT6A-mediated enhancement of trophoblast invasion, potentially via MYC signaling, contributes to PAS pathogenesis. This work provides a potential circulating biomarker for monitoring PAS progression and implicates KRT6A as a candidate therapeutic target for mitigating excessive placental invasion.<\/jats:p>","DOI":"10.3390\/cells15131204","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:04:44Z","timestamp":1782986684000},"page":"1204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KRT6A Is a Biomarker of PAS Progression and Enhances the Invasive Ability of Trophoblast Cells"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-8297","authenticated-orcid":false,"given":"Zhirong","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China"},{"name":"Beijing Key Laboratory of Innovations and Transformations in Intelligent and Precise Diagnosis and Treatment Technologies for Reproductive Health, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiation Therapy, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiran","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China"},{"name":"Beijing Key Laboratory of Innovations and Transformations in Intelligent and Precise Diagnosis and Treatment Technologies for Reproductive Health, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruochong","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China"},{"name":"Beijing Key Laboratory of Innovations and Transformations in Intelligent and Precise Diagnosis and Treatment Technologies for Reproductive Health, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China"},{"name":"Beijing Key Laboratory of Innovations and Transformations in Intelligent and Precise Diagnosis and Treatment Technologies for Reproductive Health, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China"},{"name":"Beijing Key Laboratory of Innovations and Transformations in Intelligent and Precise Diagnosis and Treatment Technologies for Reproductive Health, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China"},{"name":"Beijing Key Laboratory of Innovations and Transformations in Intelligent and Precise Diagnosis and Treatment Technologies for Reproductive Health, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta Accreta Spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"534.e1","DOI":"10.1016\/j.ajog.2021.04.233","article-title":"Trends, characteristics, and outcomes of placenta accreta spectrum: A national study in the United States","volume":"225","author":"Matsuzaki","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajog.2019.01.233","article-title":"Prevalence and main outcomes of placenta accreta spectrum: A systematic review and meta-analysis","volume":"221","author":"Jauniaux","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/FM9.0000000000000183","article-title":"High Risk Factors for Placenta Accreta Other than Pregnancy and Their Impact on Patient Prognosis","volume":"5","author":"Yang","year":"2023","journal-title":"Matern.-Fetal Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-025-00624-3","article-title":"Placenta accreta spectrum","volume":"11","author":"Jauniaux","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ijgo.12406","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bpobgyn.2020.06.007","article-title":"A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders","volume":"72","author":"Jauniaux","year":"2020","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/FM9.0000000000000126","article-title":"Expert Opinion on Placenta Accreta Spectrum Disorders in China","volume":"3","author":"Yan","year":"2021","journal-title":"Matern.-Fetal Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/GRF.0000000000000392","article-title":"Pathophysiology of Placenta Accreta Spectrum Disorders: A Review of Current Findings","volume":"61","author":"Jauniaux","year":"2018","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/AOG.0b013e31820094f3","article-title":"The effects of decidual injury on the invasion potential of trophoblastic cells","volume":"117","author":"Garmi","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.placenta.2012.09.004","article-title":"Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta\u2014An immunohistochemical study","volume":"33","author":"Hannon","year":"2012","journal-title":"Placenta"},{"key":"ref_12","first-page":"1795","article-title":"Placenta accreta: Diagnosis, management and the molecular biology of the morbidly adherent placenta","volume":"29","author":"Goh","year":"2016","journal-title":"J. Matern. Fetal Neona."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/35015709","article-title":"Proteomics to study genes and genomes","volume":"405","author":"Pandey","year":"2000","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-022-01526-8","article-title":"Proteomics technologies for cancer liquid biopsies","volume":"21","author":"Ding","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature01514","article-title":"Disease proteomics","volume":"422","author":"Hanash","year":"2003","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s11427-017-9175-2","article-title":"Recent progress in mass spectrometry proteomics for biomedical research","volume":"60","author":"Li","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1038\/s41467-020-19706-9","article-title":"Immune suppression in the early stage of COVID-19 disease","volume":"11","author":"Tian","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and Metabolomic Characterization of COVID-19 Patient Sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10760296211070580","DOI":"10.1177\/10760296211070580","article-title":"Association Between Pre-delivery Coagulation Indicators and Invasive Placenta Accreta Spectrum","volume":"28","author":"Guo","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Guo, Z., Han, X., Zheng, W., Yang, H., and Ma, J. (2022). Placenta Accreta Spectrum Among Multiple Gestation: A Retrospective Analysis Based on a Chinese Population. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.862785"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1038\/s41379-020-0569-1","article-title":"Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: Recommendations from an expert panel","volume":"33","author":"Hecht","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1080\/14767058.2020.1847077","article-title":"Validation of a scoring system for prediction of obstetric complications in placenta accreta spectrum disorders","volume":"35","author":"Zheng","year":"2021","journal-title":"J. Matern. Fetal Neona."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/pr800545q","article-title":"Standard operating procedures for serum and plasma collection: Early detection research network consensus statement standard operating procedure integration working group","volume":"8","author":"Tuck","year":"2009","journal-title":"J. Proteome Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41420-023-01670-0","article-title":"A comprehensive review of human trophoblast fusion models: Recent developments and challenges","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_26","unstructured":"Wickham, H., Chang, W., Henry, L., Pedersen, T.L., Takahashi, K., Wilke, C., Woo, K., Yutani, H., and Dunnington, D. (2026, June 28). ggplot2: Create Elegant Data Visualisations Using the Grammar of Graphics. Available online: https:\/\/CRAN.R-project.org\/package=ggplot2."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ma, J., Liu, Y., Guo, Z., Sun, R., Yang, X., Zheng, W., Ma, Y., Rong, Y., Wang, H., and Yang, H. (2022). The diversity of trophoblast cells and niches of placenta accreta spectrum disorders revealed by single-cell RNA sequencing. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1044198"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41598-024-53324-5","article-title":"Determination of biomarker candidates for the placenta accreta spectrum by plasma proteomic analysis","volume":"14","author":"Melekoglu","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"dev163428","DOI":"10.1242\/dev.163428","article-title":"Development of the human placenta","volume":"146","author":"Turco","year":"2019","journal-title":"Development"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41422-018-0066-y","article-title":"Single-cell RNA-seq reveals the diversity of trophoblast subtypes and patterns of differentiation in the human placenta","volume":"28","author":"Liu","year":"2018","journal-title":"Cell Res."},{"key":"ref_32","first-page":"3340","article-title":"A preliminary transcriptome map of non-small cell lung cancer","volume":"62","author":"Fujii","year":"2002","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cncr.25592","article-title":"A transcriptional network signature characterizes lung cancer subtypes","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1684\/ejd.2012.1773","article-title":"Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma","volume":"22","author":"Du","year":"2012","journal-title":"Eur. J. Dermatol. EJD"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1083\/jcb.201712130","article-title":"Keratin 6 regulates collective keratinocyte migration by altering cell-cell and cell-matrix adhesion","volume":"217","author":"Wang","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_36","first-page":"3477","article-title":"Keratin 6A gene silencing suppresses cell invasion and metastasis of nasopharyngeal carcinoma via the \u03b2-catenin cascade","volume":"19","author":"Chen","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1533033820921248","DOI":"10.1177\/1533033820921248","article-title":"KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma","volume":"19","author":"Yang","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Che, D., Wang, M., Sun, J., Li, B., Xu, T., Lu, Y., Pan, H., Lu, Z., and Gu, X. (2021). KRT6A Promotes Lung Cancer Cell Growth and Invasion Through MYC-Regulated Pentose Phosphate Pathway. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.694071"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"71759","DOI":"10.18632\/oncotarget.17606","article-title":"Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma","volume":"8","author":"Xiao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/crj.13182","article-title":"Anti-tumour effects of Keratin 6A in lung adenocarcinoma","volume":"14","author":"Xiao","year":"2020","journal-title":"Clin. Respir. J."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:40:03Z","timestamp":1782988803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":40,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cells15131204"],"URL":"https:\/\/doi.org\/10.3390\/cells15131204","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}